These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 10290754)
41. The formulary decision-making process in a US academic medical centre. Nash DB; Catalano ML; Wordell CJ Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985 [TBL] [Abstract][Full Text] [Related]
44. Evaluating a restrictive formulary system by assessing nonformulary-drug requests. Green JA; Chawla AK; Fong PA Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350 [TBL] [Abstract][Full Text] [Related]
45. Chairman of the Joint Formulary Committee, British National Formulary. Kendall M Clin Med (Lond); 2009 Aug; 9(4):349-52. PubMed ID: 19728509 [No Abstract] [Full Text] [Related]
47. Antibiotic review: the experience of one pharmacy and therapeutics committee. Kiepert DR QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376 [No Abstract] [Full Text] [Related]
49. Effect of a selective restriction policy on antibiotic expenditure and use: an institutional model. Suwangool P; Moola-Or P; Waiwatana A; Sitthi-Amorn C; Israsena S; Hanvanich M J Med Assoc Thai; 1991 Jul; 74(7):272-5. PubMed ID: 1765742 [TBL] [Abstract][Full Text] [Related]
50. Formulary evaluation of third-generation cephalosporins using decision analysis. Cano SB; Fujita NK Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673 [TBL] [Abstract][Full Text] [Related]
51. Use of ampicillin-sulbactam before and after formulary inclusion. Koch KE; Taylor MR Am J Hosp Pharm; 1991 Jul; 48(7):1492-6. PubMed ID: 1882880 [TBL] [Abstract][Full Text] [Related]
52. Organization and operation of P & T Committees in the state of Florida: a survey. Hatton RC; Doering PL Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259 [TBL] [Abstract][Full Text] [Related]
53. Cost containment efforts of a pharmacy and therapeutics committee. Slavick HE; Simon LS QRB Qual Rev Bull; 1984 Feb; 10(2):38-41. PubMed ID: 6424076 [No Abstract] [Full Text] [Related]
54. Pharmaceuticals in Australia: priorities in a teaching hospital. Kearney BJ Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953 [TBL] [Abstract][Full Text] [Related]
55. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion. Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560 [No Abstract] [Full Text] [Related]
56. Developing a unit-of-use drug distribution system for the hospital emergency room. Schiavone JD Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101 [TBL] [Abstract][Full Text] [Related]
57. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective. D'Sa MM; Hill DS; Stratton TP Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270 [TBL] [Abstract][Full Text] [Related]
58. Pharmacoeconomics and formulary decision making. Sanchez LA Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112 [TBL] [Abstract][Full Text] [Related]
59. Praxis makes perfect? Fins JJ Hastings Cent Rep; 1993; 23(5):16-9. PubMed ID: 7710462 [TBL] [Abstract][Full Text] [Related]